DEXCOM INC Insider Trading for September 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DEXCOM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in DEXCOM INC for September 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | S | 94.00 | 10,300 | 968,196 | 131,009 | 141.3 K to 131 K (-7.29 %) |
| Sep 27 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 93.97 | 3,182 | 299,000 | 28,643 | 31.8 K to 28.6 K (-10.00 %) |
| Sep 23 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | S | 93.99 | 2,470 | 232,155 | 76,686 | 79.2 K to 76.7 K (-3.12 %) |
| Sep 22 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 92.87 | 5,000 | 464,366 | 116,342 | 121.3 K to 116.3 K (-4.12 %) |
| Sep 22 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Gift | G | 0.00 | 290 | 0 | 50,556 | 50.8 K to 50.6 K (-0.57 %) |
| Sep 16 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | S | 91.79 | 7,000 | 642,527 | 306,891 | 313.9 K to 306.9 K (-2.23 %) |
| Sep 14 2016 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 93.00 | 10,000 | 930,000 | 0 | 10 K to 0 (-100.00 %) |
| Sep 14 2016 | DXCM | DEXCOM INC | KAHN BARBARA | Director | Sell | S | 92.90 | 5,000 | 464,512 | 24,304 | 29.3 K to 24.3 K (-17.06 %) |
| Sep 14 2016 | DXCM | DEXCOM INC | KAHN BARBARA | Director | Sell | S | 30.11 | 7,500 | 225,854 | 4,791 | 12.3 K to 4.8 K (-61.02 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 94.07 | 25,000 | 2,351,788 | 17,246 | 42.2 K to 17.2 K (-59.18 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 93.72 | 3,525 | 330,373 | 77,575 | 81.1 K to 77.6 K (-4.35 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 93.72 | 6,114 | 573,021 | 81,100 | 87.2 K to 81.1 K (-7.01 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 93.65 | 3,560 | 333,392 | 87,214 | 90.8 K to 87.2 K (-3.92 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 93.72 | 4,223 | 395,791 | 83,582 | 87.8 K to 83.6 K (-4.81 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 93.72 | 4,445 | 416,597 | 87,805 | 92.3 K to 87.8 K (-4.82 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 93.72 | 6,312 | 591,577 | 141,309 | 147.6 K to 141.3 K (-4.28 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 93.72 | 4,001 | 374,984 | 147,621 | 151.6 K to 147.6 K (-2.64 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 93.72 | 4,223 | 395,791 | 121,342 | 125.6 K to 121.3 K (-3.36 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | D | 93.72 | 4,445 | 416,597 | 125,565 | 130 K to 125.6 K (-3.42 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 93.72 | 3,525 | 330,373 | 77,575 | 81.1 K to 77.6 K (-4.35 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 93.72 | 6,114 | 573,021 | 81,100 | 87.2 K to 81.1 K (-7.01 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 93.65 | 3,560 | 333,392 | 87,214 | 90.8 K to 87.2 K (-3.92 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 93.72 | 3,556 | 333,278 | 79,156 | 82.7 K to 79.2 K (-4.30 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 93.72 | 2,667 | 249,958 | 82,712 | 85.4 K to 82.7 K (-3.12 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 93.72 | 3,556 | 333,279 | 50,846 | 54.4 K to 50.8 K (-6.54 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 93.72 | 4,445 | 416,597 | 54,402 | 58.8 K to 54.4 K (-7.55 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 65.80 | 6,666 | 438,623 | 58,847 | 52.2 K to 58.8 K (+12.77 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 95.80 | 8,333 | 798,301 | 52,181 | 43.8 K to 52.2 K (+19.00 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 95.80 | 6,666 | 638,603 | 61,334 | 68 K to 61.3 K (-9.80 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 95.80 | 8,333 | 798,301 | 68,000 | 76.3 K to 68 K (-10.92 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 7.63 | 12,000 | 91,560 | 13,583 | |
| Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 92.06 | 7,071 | 650,965 | 3,499 | 10.6 K to 3.5 K (-66.90 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 93.72 | 4,001 | 374,984 | 10,570 | 14.6 K to 10.6 K (-27.46 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 93.72 | 6,312 | 591,578 | 14,571 | 20.9 K to 14.6 K (-30.23 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 95.80 | 7,500 | 718,500 | 20,883 | 13.4 K to 20.9 K (+56.04 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 95.80 | 11,833 | 1,133,601 | 13,383 | 1.6 K to 13.4 K (+763.42 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 95.80 | 7,500 | 718,500 | 72,334 | 79.8 K to 72.3 K (-9.39 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 95.80 | 11,833 | 1,133,601 | 79,834 | 91.7 K to 79.8 K (-12.91 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 93.66 | 12,000 | 1,123,909 | 91,667 | 103.7 K to 91.7 K (-11.58 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 7.63 | 12,000 | 91,560 | 103,667 | 91.7 K to 103.7 K (+13.09 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 93.72 | 13,335 | 1,249,791 | 313,891 | 327.2 K to 313.9 K (-4.08 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 93.72 | 8,001 | 749,875 | 327,226 | 335.2 K to 327.2 K (-2.39 %) |
| Sep 13 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | D | 93.72 | 2,203 | 206,471 | 449,283 | 451.5 K to 449.3 K (-0.49 %) |
| Sep 09 2016 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 94.63 | 1,800 | 170,325 | 15,643 | 17.4 K to 15.6 K (-10.32 %) |
| Sep 09 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 3.19 | 4,999 | 15,947 | 0 | |
| Sep 09 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 94.45 | 4,999 | 472,156 | 130,010 | 135 K to 130 K (-3.70 %) |
| Sep 09 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 3.19 | 4,999 | 15,947 | 135,009 | 130 K to 135 K (+3.85 %) |
| Sep 09 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 95.59 | 5,145 | 491,830 | 65,882 | 71 K to 65.9 K (-7.24 %) |
| Sep 09 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 95.01 | 5,595 | 531,571 | 71,027 | 76.6 K to 71 K (-7.30 %) |
| Sep 06 2016 | DXCM | DEXCOM INC | LORD JONATHAN T MD | Director | Sell | S | 91.50 | 10,000 | 915,000 | 52,820 | 62.8 K to 52.8 K (-15.92 %) |
| Sep 01 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 92.14 | 10,000 | 921,356 | 76,622 | 86.6 K to 76.6 K (-11.54 %) |